Gladstone Institutional Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $922K | Buy |
8,319
+43
| +0.5% | +$4.77K | 0.04% | 359 |
|
|
2025
Q1 | $927K | Buy |
8,276
+4,661
| +129% | +$522K | 0.04% | 342 |
|
|
2024
Q4 | $334K | Sell |
3,615
-289
| -7% | -$26.7K | 0.02% | 557 |
|
|
2024
Q3 | $327K | Sell |
3,904
-9,014
| -70% | -$756K | 0.02% | 554 |
|
|
2024
Q2 | $886K | Buy |
12,918
+182
| +1% | +$12.5K | 0.05% | 316 |
|
|
2024
Q1 | $933K | Sell |
12,736
-819
| -6% | -$60K | 0.05% | 298 |
|
|
2023
Q4 | $1.1M | Sell |
13,555
-252
| -2% | -$20.4K | 0.06% | 277 |
|
|
2023
Q3 | $1.03M | Buy |
13,807
+511
| +4% | +$38.3K | 0.07% | 263 |
|
|
2023
Q2 | $1.02M | Sell |
13,296
-97
| -0.7% | -$7.48K | 0.06% | 271 |
|
|
2023
Q1 | $1.11M | Sell |
13,393
-2,158
| -14% | -$179K | 0.07% | 263 |
|
|
2022
Q4 | $1.34M | Buy |
15,551
+452
| +3% | +$38.8K | 0.09% | 240 |
|
|
2022
Q3 | $931K | Buy |
15,099
+1,180
| +8% | +$72.8K | 0.07% | 281 |
|
|
2022
Q2 | $860K | Buy |
13,919
+1,084
| +8% | +$67K | 0.07% | 302 |
|
|
2022
Q1 | $763K | Buy |
12,835
+1,050
| +9% | +$62.4K | 0.05% | 347 |
|
|
2021
Q4 | $856K | Buy |
+11,785
| New | +$856K | 0.07% | 288 |
|
|
2020
Q4 | – | Sell |
-5,204
| Closed | -$329K | – | 308 |
|
|
2020
Q3 | $329K | Buy |
5,204
+1,497
| +40% | +$94.6K | 0.08% | 196 |
|
|
2020
Q2 | $285K | Sell |
3,707
-4,631
| -56% | -$356K | 0.07% | 180 |
|
|
2020
Q1 | $623K | Buy |
8,338
+4,837
| +138% | +$361K | 0.16% | 126 |
|
|
2019
Q4 | $227K | Sell |
3,501
-497
| -12% | -$32.2K | 0.06% | 241 |
|
|
2019
Q3 | $253K | Buy |
+3,998
| New | +$253K | 0.06% | 231 |
|